Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102190565A details a novel Wittig-Horner route for C-14 aldehyde, offering cost reduction and scalable manufacturing for vitamin A intermediates.
Patent CN114853648B reveals a metal-free route to asymmetric disulfides using NBS at 25°C. This method offers significant cost reduction in fine chemical manufacturing and improved supply chain reliability.
Novel maleic diester route for 3-aminomethyltetrahydrofuran. High yield, low cost, scalable process for dinotefuran intermediates.
Patent CN101602656A details a high-yield hinokitiol synthesis using a novel toluene-based ring expansion system, offering significant cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN111303089B details a mild Mn-mediated trifluoromethylation. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable room temperature processes.
Novel rhodium-catalyzed route for ((1R,8S,9S,Z)-bicyclo[6.1.0]non-4-en-9-yl)methanol eliminates chromatography, offering scalable bioorthogonal chemistry solutions.
Patent CN106701882A details a novel chemo-enzymatic route for UDCA production offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Patent CN111704604B reveals a high-yield convergent route for pyridine quinazoline, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Novel three-step synthesis of Chrysin improves yield and purity. Cost-effective manufacturing solution for pharmaceutical intermediates supply chain.
Patent CN120136946B reveals a one-pot dienogest method reducing waste and cost. Enhances supply chain reliability for high-purity API manufacturing globally.
Patent CN117603169B reveals a novel route for pilocarpine intermediates. Achieve higher yields and safer scale-up for pharmaceutical manufacturing supply chains.
Patent CN112300184B details a high-yield route for racemic camptothecin intermediates. Discover cost-effective manufacturing and supply chain advantages for API production.
Patent CN117105817B details safe synthesis avoiding toxic cyanide. Reliable supplier for pharmaceutical intermediates ensuring cost reduction and supply continuity.
Patent CN110563696B reveals a robust method for heteroatom-containing cyclohexene halides, offering significant cost reduction and simplified purification for fine chemical manufacturing.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Patent CN100408555C reveals a high-yield synthesis of 4-chloro-3-hydroxybutyronitrile using basic catalysts, offering significant cost reduction and waste minimization for supply chains.
Advanced esterification process for Metronidazole Benzoate yielding 91.5-95%. Offers significant cost reduction in pharma manufacturing through efficient solvent recycling.
Novel palladium-free synthesis of 3-methylbenzo[d]oxazol-2(3H)-one-5-boronic acid pinacol ester. High purity >99%, total yield >81%, cost-effective API intermediate manufacturing.
Patent CN107899611B details bifunctional catalysts combining cinchona alkaloids and porphyrins for visible-light driven asymmetric synthesis, offering greener pharmaceutical intermediate production.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.